Breast Adenocarcinoma
Conditions
Brief summary
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Interventions
DIAGNOSTIC_TESTTo explore the value of spectral CT in the diagnosis and treatment of breast cancer
The CT scan is part of the standard treatment protocol.
Sponsors
Yunnan Cancer Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* (a) Chest quark energy spectrum CT examination was performed within 1 week before treatment * (b) Age ≥ 18 * (c) Suspected breast cancer patients * (d) Patients who signed informed consent
Exclusion criteria
* (a) Severe cardiac, pulmonary and renal insufficiency * (b) Allergic to iodine contrast media * (c) Unable to cooperate to complete CT examination * (d) Quark spectrum CT image is poor and cannot be used * (e) Male, pregnant and lactating female * (f) Combined with other tumor history * (g) Incomplete clinical and pathological data * (h) Pathologically confirmed non breast cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pathological TNM staging | 1 day | Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded |
Contacts
Primary ContactCaiyang Li
Backup ContactZhenhui Li
Outcome results
None listed